Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 1
2010 1
2012 1
2013 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Interferon alpha plus ribavirin combination treatment of Japanese chronic hepatitis C patients with HCV genotype 2: a project of the Kyushu University Liver Disease Study Group.
Furusyo N, Katoh M, Tanabe Y, Kajiwara E, Maruyama T, Shimono J, Sakai H, Nakamuta M, Nomura H, Masumoto A, Shimoda S, Takahashi K, Azuma K, Hayashi J; Kyushu University Liver Disease Study Group. Furusyo N, et al. World J Gastroenterol. 2006 Feb 7;12(5):784-90. doi: 10.3748/wjg.v12.i5.784. World J Gastroenterol. 2006. PMID: 16521196 Free PMC article. Clinical Trial.
Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C.
Kainuma M, Furusyo N, Kajiwara E, Takahashi K, Nomura H, Tanabe Y, Satoh T, Maruyama T, Nakamuta M, Kotoh K, Azuma K, Shimono J, Shimoda S, Hayashi J; Kyushu University Liver Disease Study Group. Kainuma M, et al. World J Gastroenterol. 2010 Sep 21;16(35):4400-9. doi: 10.3748/wjg.v16.i35.4400. World J Gastroenterol. 2010. PMID: 20845506 Free PMC article. Clinical Trial.
Relationship between body surface area and ALT normalization after long-term lamivudine treatment.
Nakamuta M, Morizono S, Tanabe Y, Kajiwara E, Shimono J, Masumoto A, Maruyama T, Furusyo N, Nomura H, Sakai H, Takahashi K, Azuma K, Shimoda S, Kotoh K, Enjoji M, Hayashi J; Kyushu University Liver Disease Study Group. Nakamuta M, et al. World J Gastroenterol. 2005 Nov 28;11(44):6948-53. doi: 10.3748/wjg.v11.i44.6948. World J Gastroenterol. 2005. PMID: 16437598 Free PMC article.
An inadequate dose of ribavirin is related to virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin.
Ogawa E, Furusyo N, Kajiwara E, Takahashi K, Nomura H, Tanabe Y, Satoh T, Maruyama T, Nakamuta M, Kotoh K, Azuma K, Dohmen K, Shimoda S, Hayashi J; Kyushu University Liver Disease Study Group. Ogawa E, et al. J Infect Chemother. 2012 Oct;18(5):689-97. doi: 10.1007/s10156-012-0396-5. Epub 2012 Mar 27. J Infect Chemother. 2012. PMID: 22450877
Body surface area is an independent factor contributing to the effects of lamivudine treatment.
Nakamuta M, Kotoh K, Tanabe Y, Kajiwara E, Shimono J, Masumoto A, Maruyama T, Furusyo N, Nomura H, Sakai H, Takahashi K, Azuma K, Shimoda S, Enjoji M, Hayashi J; Kyushu University Liver Disease Study Group. Nakamuta M, et al. Hepatol Res. 2005 Jan;31(1):13-17. doi: 10.1016/j.hepres.2004.11.004. Epub 2004 Dec 28. Hepatol Res. 2005. PMID: 15652465